Evolus Inc (EOLS)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Evolus Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 7 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 5.80 $ — 36% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 152.9% above the current price.
- Consensus
- Strong Sell
- Analyst Ratings
- 7
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.09 | -0.14 – -0.05 | 331 | 78.6% | 5 |
| 12/31/2027 | 0.24 | 0.18 – 0.29 | 388 | 355.3% | 5 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.09 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.11 | – | 79 | 29.40 | -8.60 | 5 | 3 |
| 2025: Q1 | -0.30 | – | 69 | 15.50 | -27.60 | -16 | -18 |
| 2025: Q2 | -0.27 | – | 69 | 3.70 | -24.70 | -25 | -26 |
| 2025: Q3 | -0.24 | – | 69 | 12.90 | -22.80 | -15 | -17 |
| 2025: Q4 | 0.00 | – | 90 | 14.40 | 0.10 | 13 | 11 |
| 2026: Q1 | -0.16 | – | 73 | 6.70 | -14.60 | -10 | -10 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 0 | -20 | -20 | -1.08 | -13 | -7 | 78 |
| 2017 | 0 | -12 | -4 | -0.19 | -13 | -76 | 152 |
| 2018 | 0 | -46 | -47 | -1.92 | -26 | 84 | 172 |
| 2019 | 35 | -99 | -90 | -3.19 | -93 | 79 | 240 |
| 2020 | 57 | -153 | -163 | -4.83 | -58 | -73 | 209 |
| 2021 | 100 | -44 | -47 | -0.94 | -33 | 82 | 257 |
| 2022 | 149 | -65 | -74 | -1.33 | -85 | 19 | 178 |
| 2023 | 202 | -49 | -62 | -1.08 | -34 | -21 | 189 |
| 2024 | 266 | -34 | -50 | -0.81 | -18 | 6 | 233 |
| 2025 | 297 | -38 | -52 | -0.80 | -42 | -23 | 226 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Evolus, Inc. , a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
| Employees | 350 |
|---|---|
| Headquarters | Newport Beach, CA |
| Address | 520 Newport Center Drive, 92660 Newport Beach, United States |
| Phone | 949 284 4555 |
| Website | evolus.com |
| IPO Date | 8. Feb 2018 |
| ISIN | US30052C1071 |
Management
| Name | Title | Birth Year |
|---|---|---|
| David Moatazedi | President, CEO & Director | 1978 |
| Tatjana Mitchell | Chief Financial Officer | – |
| Rui Avelar C.CFP, Dip.SportMed, M.D. | Chief Medical Officer and Head of Research & Development | 1962 |
| Nareg Sagherian | Head of Global Investor Relations & Corporate Communications | – |
| Kurt Knab | Senior Vice President of Sales | – |
| Jessica Novak | Senior Vice President of Human Resources | – |
| Jeffrey J. Plumer | Corporate Secretary | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.